Switzerland Neurology Devices Market Analysis Report 2022 to 2030

Switzerland Neurology Devices Market Analysis

$ 3999

The Switzerland Neurology Device Market Size has valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The neurology devices market in Switzerland is expanding as a result of factors such as an ageing population, technological improvements, and an increase in the frequency of neurological disorders. The market is segmented by product type and by the end user. Some key players in this market include Sleepiz, Medtronic, Parayil, Abbott and Boston Scientific.

ID: IN10CHMD012 CATEGORY: Medical Devices GEOGRAPHY: Switzerland AUTHOR: Jigyasu Bhandari

Buy Now

Switzerland Neurology Device Market Executive Analysis

The Switzerland neurology devices market is at around $xx Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period. In 2016, total health spending in Switzerland was $66.7, or 12.2% of the country's GDP. 62.8% of health spending in Switzerland, or 7.7% of GDP, is covered by public health insurance. In 2020, Switzerland spent 11.9% of its GDP on healthcare per person, the most in all of Europe. The healthcare system in Switzerland is among the most expensive in the world. About 12% of the country's GDP is spent on healthcare (GDP). Only one of the 37 members of the Organization for Economic Cooperation and Development (OECD), the United States, spends more on healthcare than that, at 17% of its GDP.

Neurology disorders are rather typical in Switzerland. The most prevalent ailments include Parkinson's disease, multiple sclerosis, epilepsy, stroke, and Parkinson's disease. Numerous people in Switzerland also suffer from other conditions as migraine, neuropathic pain, and neuromuscular illnesses. The precise prevalence and incidence rates of particular diseases may vary depending on a variety of factors, including age, gender, and ethnicity. Access to healthcare resources and services may also have an impact on the prevalence and incidence rates of neurological illnesses and disorders in Switzerland. Although deep brain stimulation devices aid in carrying out therapies by implanting a medical device that delivers electrical impulses to specific target regions in the brain, interventional devices employ radiography and catheters to diagnose the illnesses existing in the patient. Numerous neurological disorders, including Alzheimer's disease, spinal cord injuries, and traumatic brain injuries, are treated, prevented, and identified with neurology devices. These neurology devices are also used to help people with limb loss or congenital limb differences regain their hearing and sight.

Market Dynamics

Market Growth Drivers

The neurology devices market in Switzerland is expanding as a result of factors such as an ageing population, technological improvements, and an increase in the frequency of neurological disorders. In Switzerland, as the population ages, there is a growing need for neurological therapies and devices. The market for neurology devices is growing as a result of the higher prevalence of Parkinson's, dementia, and Alzheimer's disease among the elderly population. The market for neurology devices is expanding as a result of technological developments like the creation of minimally invasive procedures, robotic-assisted operations, and neurostimulation devices. These innovations have sped up recovery times, decreased the risk of complications, and enhanced patient outcomes. In Switzerland, the prevalence of neurological diseases like epilepsy, Alzheimer's, and Parkinson's is rising. As a result, the market for neurology devices is experiencing chances for growth due to an increase in the need for diagnostic and treatment devices.

Market Restraints

Switzerland's market for neurology equipment is constrained by a number of factors, such as strict regulations and limited reimbursement procedures. The Switzerland neurology devices market is strictly regulated, and severe guidelines for safety and effectiveness apply. The development research and commercialization of new neurological devices may become more difficult and expensive as a result of these regulations.

Competitive Landscape

Key Players

Sleepiz AG (CH)
Optiswiss (CH)
Parayil (CH)
Medtronic
Abbott Laboratories
Nihon Kohden
Boston Scientific

Notable Recent Deals

Companies from the United States are supplying the Switzerland market with cutting-edge pharmaceutical and medtech products. Additionally, U.S. businesses might be able to work with Novartis, Roche, and other Swiss-based pharmaceutical giants to meet their needs.

Healthcare Policies and Regulatory Landscape

The Medical Device Regulation (MDR) and In Vitro Diagnostic Medical Device Regulation (IVDR) have been included in Switzerland's national medical device laws in order to maintain parity with European Union (EU) regulations. In order to increase the safety of medical devices, the EU passed the Medical Device Regulation (MDR) and the In Vitro Diagnostic Medical Device Regulation (IVDR). Both regulations, which replaced the aforementioned earlier Directives, went into effect in 2017. According to the European Commission, Swiss manufacturers must mandate a qualified EU representative (EU-REP) and label their medical devices with the necessary information about the EU-REP as of May 26, 2021, in order to continue selling their medical devices in EU/EEA countries.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Neurology Device Market Segmentation

The Neurology Device Market is segmented as mentioned below:

By Product Type (Revenue, USD Billion):

Neurostimulation
?Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Gastric Electric Stimulation
Interventional Neurology
- Aneurysm Coiling & Embolization
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Cerebral Balloon Angioplasty & Stenting
- Carotid Artery Stents
- Filter Devices
- Balloon Occlusion Devices
- Neurothrombectomy
- Clot Retriever
- Suction Aspiration Devices
- Snares
CSF Management
- CSF Shunts
- CSF Drainage
Neurosurgery Devices
- Ultrasonic Aspirators
- Stereotactic Systems
- Neuroendoscopes
- Aneurysm Clips

By End User (Revenue, USD Billion):

??Hospitals and Clinics
Specialty Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.